Transgenomic Inks Second Pact to Evaluate Ice-Cold-PCR for Blood-Based Cancer Mutation Detection
September 06, 2012
Transgenomic Inks Second Pact to Evaluate Ice-Cold-PCR for Blood-Based Cancer Mutation Detection
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Transgenomic, NYU-Langone Partner to Study NSCLC Using Ice-Cold-PCR
September 4, 2012 / GenomeWeb Daily News - FDA Approves Roche Test as CDx for Tarceva for Treating Certain NSCLC Patients
May 15, 2013 / GenomeWeb Daily News - Dana Farber Team Looks to 'Dissect' Cancer Gene Mutations Using Novel Enrichment Technique
February 14, 2013 / PCR Insider - Insight Genetics Wins $1.5M Grant to Begin Clinical Testing for ALK Mutation CDx on Qiagen Platform
October 11, 2012 / PCR Insider - Case Study Suggests FISH Test May Miss Some Patients Who Could Benefit from Crizotinib
September 12, 2012 / Pharmacogenomics Reporter